Real-world Treatment Patterns of Novel Drugs in Relapsed or Refractory Acute Lymphoblastic Leukemia Patients in Japan.
FUTURE ONCOLOGY（2023）
关键词
acute lymphoblastic leukemia,blinatumomab,database study,inotuzumab,Japanese claims data,minimal residual disease,prescription pattern,real-world,relapsed or refractory,subsequent therapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要